Articles tagged with Eye Diseases
The Genetic Eye Disease (GEDi) test, developed by Massachusetts Eye and Ear, is a comprehensive genetic test for inherited eye disorders. It includes all known genes associated with these conditions and has been shown to be 98% accurate in detecting genetic variants, outperforming whole exome sequencing.
Researchers at Mount Sinai aim to re-create patients' ocular stem cells to restore vision, eliminating the need for immunosuppressive drugs. The grant will support efforts to discover new stem cell therapies and develop biomaterials for engrafting patient-owned stem cells.
Researchers at University of Melbourne developed a new laser treatment that improves eye health in AMD patients by reducing disease signs and enhancing supporting cells. The nanosecond laser does not cause damage to the retina, raising hope for monocular treatment options.
Researchers have developed microneedles that can deliver drugs to specific areas within the eye, targeting two major diseases: glaucoma and corneal neovascularization. The treatment has shown promising results in reducing intraocular pressure and halting unwanted blood vessel growth.
A study of 4,379 participants found that having AMD in one eye increases the risk of developing AMD in the other eye, with more severe disease progressing faster. The researchers tracked AMD severity in both eyes over a 20-year period and found a strong correlation between the two eyes.
A study using a free peripheral vision assessment app on iPads screens approximately 200 patients in Nepal for glaucoma, showing promise for populations with limited access to traditional eye care. The results agree between 51-79% with the industry standard test and can be an effective initial screening tool for high-risk groups.
Researchers studying blind cave fish are uncovering insights into degenerative eye disease and sleep disturbance. The species' genome sequence reveals similarities with the human genome, suggesting potential avenues for understanding human diseases.
A large retrospective study found that nearly 60% of patients with both uveitis and multiple sclerosis (MS) are diagnosed with each condition within a five-year span. The study also revealed that MS is more likely to be diagnosed before or after uveitis, not simultaneously.
A new smartphone-based tool has been developed to monitor diabetic eye disease, offering comparable results to traditional equipment. The tool, called D-Eye, uses a small optical adapter that attaches magnetically to an iPhone and enables ophthalmologists to evaluate the severity of the disease.
Researchers at IRCM uncover the essential role of a protein called Numb in maintaining proper compartmentalization within photoreceptor cells, leading to vision loss and degenerative diseases like retinitis pigmentosa. The discovery could provide novel drug targets for preventing photoreceptor degeneration.
Ferrara's discovery of vascular endothelial growth factor (VEGF) led to the development of ranibizumab, a monoclonal antibody drug treating wet macular degeneration and diabetic eye disease. This achievement has significantly improved vision for patients affected by these conditions.
Researchers at Northwestern University identify a critical chemical signaling pathway for the healthy functioning of Schlemm's canal, a key factor in developing glaucoma. They are now developing an eye drop that activates regrowth of the clogged vessel to lower pressure and restore normal drainage.
Researchers found that statin use decreased the risk of diabetic neuropathy, retinopathy, and gangrene in individuals with diabetes. However, statin use did not affect the risk of kidney disease.
A team of researchers has identified a new target for treatment of common eye diseases, including wet macular degeneration and diabetic macular edema. Activating a biochemical pathway that suppresses VEGF's effects may offer a safer alternative to current treatments.
A study of over 4,000 UK women found that dry eye disease affects nearly one-tenth of the population, with symptoms worsening with age. The condition is linked to various health issues, including pain syndromes, autoimmune diseases, and fertility problems.
Researchers have created a high-resolution molecular map of the choroid, supplying blood and oxygen to the outer retina, revealing patterns of protein abundance that may be critical in vision loss. The map helps explain why certain areas are more susceptible to disease and identifies potential treatment targets.
A new study published in PLOS Biology reveals that Schlemm's canal forms from blood vessels through a novel process called canalogenesis. This discovery sheds light on the complex functions of Schlemm's canal, which plays a critical role in maintaining ocular health and preventing diseases like glaucoma.
Researchers found that dietary iodine intake was inversely related to central foveal swelling in RP patients with CME. This finding suggests that an iodine supplement could help limit or reduce retinal swelling in these patients.
Researchers have discovered that acute glaucoma is an inflammatory disease caused by high eye pressure, leading to vision loss. The study found that a rapid increase in eye pressure triggers an immune response that damages retinal cells.
Columbia University researchers create a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss. They use induced pluripotent stem cell technology to transform skin cells into retinal cells, which are then used as patient-specific models for disease study and preclinical testing.
The LA BioMed project aims to develop integrated and comprehensive care models to help Centinela Valley residents manage their diabetes. The goal is to prevent long-term complications such as kidney failure, amputations, and blindness.
Research shows higher education levels and more years spent in school are associated with a greater prevalence and severity of nearsightedness. Outdoor activity and exposure to daylight are linked to reduced risk of myopia, suggesting environmental factors may outweigh genetics in its development.
Wolfgang Baehr will receive the Nelson Trust Award and funding to continue researching retinal diseases that lead to blindness. The award supports his work on understanding phototransduction and retina diseases.
A new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that hyperthyroidism patients are more likely to take extended sick leave, particularly in the first year after diagnosis. People with eye complications from Graves' disease were the most likely to require extended sick leave.
Researchers found that omega-3 fatty acids can regulate choroidal angiogenesis and vascular leakage by modulating micro-environmental immune cell recruitment. This mechanism suggests a unique pathway for disease resolution and potential therapeutic applications in age-related macular degeneration.
UK researchers are developing new materials to create artificial corneas and contact lenses that can be manufactured in an environmentally friendly way. The project aims to reduce the financial impact of vision loss on individuals and the economy, with potential breakthroughs in treating age-related macular degeneration.
A study found that tobacco exposure and male sex are significant risk factors for developing ocular sarcoidosis, which affects 25-50% of patients with the disease. The risk is greater than 5-fold for those exposed to tobacco and more than 7-fold for males.
Researchers developed a novel compound, Sticky-trap, to treat retinopathy by selectively closing off abnormal blood vessels without affecting healthy ones. The treatment has shown promise in mice and may lead to a new class of pharmacological entities for various conditions.
A team of mathematicians and optometrists developed a mathematical model to better understand the inner workings of tear film distribution over the eye's surface. Their findings suggest that it takes a blink to redistribute tear film, which may aid in the development of better treatments for dry eye disease.
Researchers have developed gene therapies to prevent and treat blinding diseases, including choroideremia and retinitis pigmentosa. These treatments involve replacing missing genes in the cells at the back of the eye, resulting in improved vision for some patients.
A study from the University of Waterloo found a correlation between abnormal binocular vision, general health, and antidepressant use in older adults. Binocular vision disorders affect depth perception and may increase fall risk, affecting up to 38% of those over 80 years old.
Joslin Medalists with type 1 diabetes for 50+ years have higher levels of endothelial progenitor cells (EPCs) and circulating progenitor cells (CPCs), associated with lower cardiovascular and kidney disease. These findings suggest that measuring CPC levels may help identify people at risk for complications.
A study published in the journal Ophthalmology found that physically active individuals and occasional drinkers have a reduced risk of developing visual impairment. The research suggests that modifiable lifestyle behaviors may alter the odds of developing sight loss not correctable with glasses or contact lenses.
Complex NHS sight tests are leading to unnecessary referrals and resource waste due to clinically insignificant abnormalities. Opticians refer patients to medical practitioners if abnormalities are found, but many of these referrals result in false positives and anxiety for patients.
Research suggests that shortening the time from symptoms to diagnosis has no bearing on survival or disease stage for most children with unilateral retinoblastoma. However, a longer lag-time between symptom onset and diagnosis is associated with a more advanced stage and worse survival in bilateral cases.
Studies suggest that eye structure and function may reveal features of early-stage Alzheimer's disease, including changes in retinal pigment epithelial layer and choroidal layer thickness. Researchers hope to develop new diagnostic methods using the eye as a window to brain activity.
Researchers found that drivers with hemianopia had lower detection rates for pedestrians on the side of their field loss due to inadequate scanning patterns. These individuals often failed to scan the entire intersection or scanned too little, increasing the risk of accidents.
Researchers at UCL have developed a new technology that can deliver the AMD drug Avastin via eye drops, potentially replacing painful injections. The system uses nanoparticles to transport the drug across biological barriers and could be customized for different medications.
Researchers found a significant decrease in cataract risk among male physicians taking a daily multivitamin supplement, with a 9% lower risk compared to the placebo group. However, the study also found a slight increase in age-related macular degeneration risk among multivitamin users.
A new compound called DENAQ has been found to restore light perception in blind mice by conferring sensitivity on ganglion cells. The treatment, which requires only a single injection, shows promise as a potential vision-restoring drug, but further testing is needed for safety and efficacy
Researchers from UCLA have developed a drug delivery system that may improve glaucoma management by reducing side effects and increasing patient compliance. The nanodiamond-drug compound was released into the eye through contact lenses, showing great promise for sustained treatment.
The genomes of King Richard III and one of his living descendants are being sequenced to shed light on his ancestry, health, and genetic makeup. The project will also analyze the genetic information of pathogens that may have caused diseases in the past.
Researchers found that moderate aerobic exercise preserved photoreceptors and retinal cell function in mice with retinal degeneration. Exercise also increased levels of BDNF, a growth- and health-promoting protein.
Researchers have designed a system-on-chip that could enable fully implanted cochlear implants, restoring hearing in individuals with profound loss. The internal unit would be wirelessly rechargeable and require lower power sound processing.
Dr. Jason I. Comander has received a $250,000 Research to Prevent Blindness Career Development Award to study patients with inherited retinal degenerations, including retinitis pigmentosa. The award aims to develop techniques for high-throughput functional characterization of human genetic variation and mutation in retinitis pigmentosa.
Massachusetts Eye and Ear Hospital has awarded Christina Marsica Grassi a $30,000 fellowship to investigate sterile vitritis in patients with artificial corneal implants. The research project aims to improve understanding of immune responses to prosthetic devices and develop better treatments for this condition.
The probability of blindness from glaucoma has decreased by nearly half since 1980, with advances in diagnosis and therapy likely contributing to the reduction. However, a significant proportion of patients still progress to blindness, emphasizing the need for continued research and vigilant eye exams.
A special issue of IOVS addresses the aging eye, focusing on unmet needs and accelerating clinical care. The issue features new research on genetics, biology, and prevention/treatment of age-related diseases such as cataracts and macular degeneration.
Researchers from Penn Vet found a shared cell death pathway involved in inherited vision diseases, including rod cone dysplasia and X-linked progressive retinal atrophy. The study suggests that targeting this pathway with TNF-inhibitors could slow disease progression or complement gene therapies.
Scientists have developed a new technique to visualize the silencing of one X chromosome in females, revealing wide-ranging variation in patterns across tissues and individuals. The study's findings offer insights into genetic diversity and disease causes, particularly for X-linked variations like hemophilia and color blindness.
Researchers identify azithromycin as a potential therapy for meibomian gland dysfunction, leading to improved treatment options for dry eye disease. The study suggests that topical azithromycin could directly stimulate the function of human meibomian gland epithelial cells.
Researchers have developed a nonsense suppression drug that can restore function in mice with aniridia, a progressive disease affecting the eyes and brain. The treatment, ataluren, was administered topically to postnatal aniridia mice and successfully reversed eye deformations and restored vision.
Researchers identified a fungal surface protein that promotes host cell invasion in mucormycosis, while others found that melanocytes from light-skinned humans secrete a molecule promoting angiogenesis. These findings could lead to new treatments and biomarkers for diseases associated with increased vascularization.
A new hand-held optical device can scan a patient's entire retina in seconds, detecting early signs of diabetic retinopathy, glaucoma and macular degeneration. This innovation enables primary care physicians to screen a wider population outside traditional specialist offices.
Researchers at UBC-VCH have developed a potential cure for aniridia, a rare eye disease affecting 5,000 people in North America. They formulated the drug Ataluren into eye drops and found it restored normal vision in mice with the condition.
A new study reveals that nearly half of Americans with diabetes are unaware of the link between the disease and visual impairment, while only six in ten have had their eyes fully examined. The research highlights the need for improved patient education and access to eye care specialists to prevent vision loss.
Two studies examine the effects of spaceflight on mouse eyes, revealing oxidative stress as a key mechanism behind eye damage. Researchers found genes involved in response to oxidative stress and potential indicators of optic nerve damage, highlighting the need for countermeasures to protect astronauts' vision.
Cardiovascular complications and hypoglycemia are common nonfatal complications in older adults with diabetes. The study found that patients with diabetes for a longer duration had higher rates of all outcomes, including mortality.
Researchers analyzed minute movements to diagnose autism and determine its severity in children and young adults. The study found that fluctuations in hand movements can indicate the degree of autism spectrum disorder, allowing for subtyping and improved diagnosis. This breakthrough may lead to more tailored treatments.
Research found that women who used oral contraceptives for three or more years are 2.05 times more likely to have glaucoma, a leading cause of blindness. The study suggests long-term use of birth control may be a risk factor for glaucoma, particularly in combination with other factors such as ethnicity and family history.